Prestige Consumer Healthcare Inc 's ROA from the first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Prestige Consumer Healthcare Inc 's ROA in the first quarter of 2026?
Prestige Consumer Healthcare Inc achieved a return on average assets (ROA) of 10.9 % in its first quarter of 2026, this is above PBH's average return on assets of 6.4%.
Prestige Consumer Healthcare Inc s assets during the 12 months ending in the first quarter of 2026 are valued at $3 billion

ROA decreased relative to the period ending Mar 31 2026, due to the decline in net income.

However, within the Healthcare sector 91 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 444, from total ROA ranking in the fourth quarter of 2026 at 487.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) I. Quarter	(Mar 31 2026) IV. Quarter	(Dec 31 2025) III. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) I. Quarter
Y / Y Total Assets Change	33.13 %	2.71 %	2.53 %	3.78 %	3.75 %
Y / Y Net Income Change	-38.01 %	-4.34 %	-23.14 %	-11.66 %	1.64 %
Net Income (TTM) in million	406	448	453	486	501
Return On Assets (TTM)	10.9 %	13.01 %	13.25 %	14.3 %	14.87 %
PBH's Total Ranking	# 444	# 487	# 382	# 351	# 355
Total Assets (TTM) in million	4,569	3,494	3,402	3,442	3,432
Seq. Total Assets Change	30.74 %	2.71 %	-1.16 %	0.31 %	0.86 %
Seq. Net Income Change	-42.95 %	9.39 %	-2.55 %	1.92 %	-11.96 %

PBH's 5 Years Annual ROA >> Back to PBH Management Effectiveness >> Compare PBH ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 38
Sector	# 92
Overall	# 560

Return On Assets Statistics
High	Average	Low
14.95 %	6.4 %	-2.46 %
(Mar 31 2025)		(Jun 30 2023)

Financial Statements
Prestige Consumer Healthcare Inc 's Assets	$ 4,569 million	PBH's Balance sheet
Prestige Consumer Healthcare Inc 's Income	$ 68 million	Quarterly PBH's Income Statement
PBH's Income by Division		See PBH's Income by Division

Annual Return On Assets	(Mar 31 2026) FY 2026	(Mar 31 2025) FY 2025	(Mar 31 2024) FY 2024	(Mar 31 2023) FY 2023	(Mar 31 2022) FY 2022
Y / Y Total Assets Change	2.71 %	2.53 %	-1.05 %	-8.63 %	7.04 %
Total Assets in million	3,494	3,402	3,318	3,354	3,671
Y / Y Net Income Change	-10.22 %	2.77 %	-	-	24.71 %
Net Income in million	448	499	485	-82	205
Annual Return On Assets	12.82 %	14.66 %	14.63 %	-2.45 %	5.6 %

PBH's 5 Years Annual ROA >> Back to PBH Management Effectiveness >> Compare PBH ROA to its Competitors

Comment on PBH's ROA in the fiscal year ending 2026

In the fiscal year 2026 Prestige Consumer Healthcare Inc 's ROA decreased compared to previous year to 12.82 %, due to deterioration of net income -10.22 % to $447.80 million, from $498.79 million a year ago, as PBH's assets were $3,494.31 million.

More Return On Assets Ratios
PBH's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PBH's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PBH's Competitors
Subscribers only: Roa for Prestige Consumer Healthcare Inc 's Suppliers
Subscribers only: Return On Assets for PBH's Customers

You may also want to know
PBH's Roi	PBH's Inventory Turnover Ratio	PBH's Growth Rates	PBH's Dividend Comparisons
	PBH's Profitability Ratios	PBH's Asset Turnover Ratio	PBH's Dividend Growth
PBH's Roe	PBH's Valuation Ratios	PBH's Financial Strength Ratios	PBH's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Meiragtx Holdings Plc	29.37 %
Indivior Pharmaceuticals Inc	28.21 %
Qhslab Inc	27.12 %
Adma Biologics Inc	26.58 %
Mettler toledo International Inc	24.86 %
Medpace Holdings Inc	24.84 %
Caredx Inc	24.81 %
Acadia Pharmaceuticals Inc	24.38 %
Eli Lilly And Company	21.97 %
Innoviva Inc	21.64 %
Vaxart Inc	20.85 %
Zevra Therapeutics Inc	20.39 %
Iradimed Corporation	20.36 %
Protalix Biotherapeutics inc	20.09 %
Pro dex Inc	19.87 %
Electromed Inc	19.39 %
United Therapeutics Corporation	17.98 %
Resmed Inc	17.80 %
Krystal Biotech Inc	17.65 %
Chemed Corporation	17.52 %
Zoetis Inc	17.19 %
Vertex Pharmaceuticals Inc	16.88 %
Halozyme Therapeutics Inc	16.55 %
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %
Dexcom Inc	14.87 %
Neurocrine Biosciences Inc	14.73 %
Entera Bio Ltd	14.60 %

Date modified: 2026-09-08T21:32:37+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.